ברקלוד 1 מ"ג
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
ENTECAVIR 1 MG
Available from:
BRISTOL, MYERS SQUIBB (ISRAEL) LIMITED
ATC code:
J05AF10
Pharmaceutical form:
FILM COATED TABLETS
Administration route:
PER OS
Manufactured by:
BRISTOL MYERS SQUIBB SPA, ITALY
Therapeutic group:
ENTECAVIR
Therapeutic indications:
Baraclude is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels. This indication is based on clinical trial data in patients with HBeAg positive and HBeAg negative HBV infection, nucleoside naive patients and patients with lamivudine-refractory hepatitis B.Decompensated liver disease.
Authorization date:
2009-02-01
